PHE has undertaken a number of rapid evaluations of commercial serological assays for their suitability for detecting the production of COVID-19 antibodies. Category: UncategorisedBy 26 May 2021Leave a commentPost navigationPreviousPrevious post:Guidance: Local Health: indicator updatesNextNext post:Form: Zoonotic and acute respiratory section: request form
